Skip to content

Wet Lab Resources and News for your Biotech Incubator, Research Park, or Association

Details are emerging for BioNJ and Pennsylvania Bio 10th Anniversary joint symposium

 

Register today at www.biotech2010.org

 

CALAsia is a global conference aimed at helping U.S. and Asian life science organizations spotlight growth, technology development and innovation in their respective regions. The two day event in San Diego on October 4-5, 2010 will focus on development strategies in the US and Pacific Rim including regulatory compliance issues facing Asian and American companies, the future of global drug discovery, and financing opportunities.

 

Application Deadline August 6, 2010 

The 
National Cancer Institute (NCI) recently introduced the Small Business Innovation Research (SBIR) Phase II Bridge Award mechanism, designed to incentivize their phase II awardees to obtain 3rd party financing in order commercialize technologies developed with SBIR funds. 

In this session, Directors from the NCI SBIR Development Center will talk to current and potential grantees about the 
Bridge Award and other opportunities such as their contract topics

After the presentation, each attendee will have a private meeting with Mr. Michael Weingarten – the Director of the NCI SBIR Development Center – and/or Dr. Ali Andalibi – the Program Director of the NCI SBIR Development Center. 

To apply for one-on-one meetings, please send your Executive Summary by August 6, 2010 toevents@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application.
Click here to visit the Meet with... Series FAQ»
Click here for more information about this NCI session» 

One-on-one Meetings
The one-on-one meetings will take place on August 24th at Townsend & Twonsend, Palo Alto, CA.

 

 

Date: Monday, August 30
Time: 8:00 am - 2:00 pm (includes lunch) 
Location: Kansas City Convention Center

 

The recent successful siting of the National Bio- and AgroDefense Facility (NBAF) in Manhattan, Kansas will have significant economic impact in the region and serve as an important component of our national biosecurity efforts.  This conference sponsored by The Kansas City Area Life Sciences Institute and the KC Animal Health Corridor brings together a number of national and regional biosecurity experts to discuss the future and science as well as risks and threats of potentially dangerous technology.  These organizations are joining forces with the veterinary schools of the University of Missouri and Kansas State University to offer this important look at the science of biosecurity.

 

Apply Today! NCI Grant Funding Available for Small Business Innovation Research in Cancer Technologies

Deadline: August 5, 2010

The National Cancer Institute (NCI) encourages you to learn more about how grant funding can help your small business or institution advance your innovative research ideas to the commercialization stage. The NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are offering grant funding opportunities to eligible small businesses and research institutions for the development and commercialization of novel technologies and products to prevent, diagnose, and treat cancer.

Franklin Allen and Glenn Yago, authors of Financing the Future: Market-Based Innovations for Growth, will discuss financial innovations as well as their views on the economic recovery and regulatory reform at a Forum scheduled for August 3 at the Milken Institute.

In Financing the Future, Allen and Yago trace the evolution of financial innovations and how they have advanced a variety of fields. The authors argue that the financial crisis offers a cautionary tale, but shouldn't be used as an opportunity to quash innovation altogether. They identify crucial differences between genuinely useful innovations and instruments designed merely to hide risk and generate quick profits.

There is no charge for the Forum, but preregistration is required. To RSVP, please register online.

 

 

University of Maine and Foster Center for Student Innovation have recently opened registration for INV 510: Innovation Engineering Accelerated course which is being offered during this upcoming fall semester. This course is open to all community members who have an undergraduate degree and current UMaine seniors and graduate students.  

INV 510 is the graduate level introductory course to the fundamentals of Innovation Engineering and is the first step to earning a graduate certificate in Innovation Engineering.  Upon completing this course, you will have gained the tools and confidence to lead in the creation, communication, and commercialization/realization of meaningfully unique ideas in any field.  You'll learn a systematic approach to creativity, the practices and principles of precise, persuasive concept writing, and key components of commercialization/realization.  INV 510 will give you the chance to help real businesses with serious needs.  The class will be held on Tuesday afternoons from 3:30-6:00. 
 
Registration Details follow

 
BIOCOM and BayBio are creating a day and a half conference that will combine the business, research and investment aspects for the industrial biotech community in this unique statewide conference. Through panel discussions, partnering opportunities and ample networking opportunities to extend your relationships. This conference will educate participants on the opportunities and challenges facing industrial biotech companies and ultimately demonstrate why California is a center of innovation in the industrial biotech space.

The upcoming LifeScience Alley meeting will host a discussion led by Dr. Jeffrey Kahn, PhD, MPH, Director, Center for Bioethics, University of Minnesota on the topic of the ethics of human clinical trials.  It is important to conduct the necessary tests when developing a novel device.  Come to the meeting and learn first hand the ethics involved and how to avoid conflicts of interest and potentially dangerous mistakes.  Read more and register.


Newly funded companies create medical innovations, help businesses improve productivity
PHILADELPHIA, PA (www.sep.benfranklin.org) – Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved investments totaling $1,800,000 for nine early-stage Pennsylvania companies with promising technology innovations.  Included in this is a $500,000 investment in Molecular Detection Inc. (MDI).  MDI developed a quick method to detect drug resistant Staph infections.  Investment details follow.

Luminogenics is a resource with interests in systems of technology commercialization in the life sciences. Included here is a directory of hundreds of biotech incubators, research parks, and associations.



Powered by Drupal, an open source content management system
AdaptiveThemes